Wave Life Sciences, Inc. (WVE)
NASDAQ: WVE · Real-Time Price · USD
4.350
-0.090 (-2.03%)
At close: Sep 18, 2026, 4:00 PM EDT
4.367
+0.017 (0.40%)
After-hours: Sep 18, 2026, 7:30 PM EDT
Wave Life Sciences Market Cap
Wave Life Sciences has a market cap or net worth of $857.16 million as of September 18, 2026. Its market cap has decreased by -20.83% in one year.
Market Cap
857.16M
Enterprise Value
410.15M
1-Year Change
-20.83%
Ranking
Category
Stock Price
$4.35
ChartMarket Cap Chart
Since November 11, 2015, Wave Life Sciences's market cap has increased from $334.93M to $857.16M, an increase of 155.92%. That is a compound annual growth rate of 9.04%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 857.16M | -72.45% |
| Dec 31, 2025 | 3.11B | 64.89% |
| Dec 31, 2024 | 1.89B | 213.58% |
| Dec 29, 2023 | 601.65M | -1.10% |
| Dec 30, 2022 | 608.37M | 229.32% |
| Dec 31, 2021 | 184.73M | -51.88% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Faeth Therapeutics | 891.49M |
| Avalo Therapeutics | 888.65M |
| Theravance Biopharma | 883.66M |
| Inventiva | 875.21M |
| Rigel Pharmaceuticals | 871.23M |
| Olema Pharmaceuticals | 859.23M |
| Ardelyx | 852.22M |
| 4D Molecular Therapeutics | 840.82M |